View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Stijn Demeester
  • Stijn Demeester

AMG/Lithium rally welcome boost in transition year/BUY

We raise our target price from €35 to €45 per share, driven by the recent recovery in lithium prices, which has the potential to turn a transition year for AMG into a more exciting one. We maintain our BUY recommendation, with AMG's valuation still undemanding, in light of the re-emergence of the critical materials theme and with key peers trading at substantial premia relative to AMG.

 PRESS RELEASE

ASSYSTEM:2025 consolidated revenue

ASSYSTEM:2025 consolidated revenue 2025 consolidated revenue: €656.6 million (up 7.4%)4.5% organic, primarily driven by robust International momentum Paris-La Défense, Tuesday 10 February 2026, 5.35 p.m. (CET) – Assystem S.A. (ISIN: FR0000074148 - ASY), an international engineering group, today released its revenue figures for the fourth quarter of 2025 and the twelve months ended 31 December 2025. 2025 consolidated revenue (unaudited) and year-on-year changes vs 2024 In millions of euros20242025% change(reported)% change(organic(2))Group(1)611.3656.6+7.4%+4.5%     France380.9387.8+1.8%+...

 PRESS RELEASE

ASSYSTEM: Chiffre d'affaires 2025

ASSYSTEM: Chiffre d'affaires 2025 Chiffre d’affaires 2025 : 656,6 M€ (+7,4%)Croissance organique (+4,5%) tirée par la dynamique à l’International Paris La Défense, le mardi 10 février 2026 à 17h35 – Assystem S.A. (ISIN : FR0000074148 - ASY), groupe international d’ingénierie, annonce aujourd’hui le chiffre d’affaires réalisé au le 4ème trimestre 2025 et sur l’ensemble de l’exercice clos le 31 décembre 2025. Chiffre d’affaires consolidé 2025 (non audité) et variations par rapport à 2024 En millions d'euros20242025Variation totaleVariation organique (2)Groupe (1)611,3656,6+7,4%+4,5%     Fra...

Baptiste Lebacq ... (+2)
  • Baptiste Lebacq
  • Jean-François Granjon

ODDO : 10 graphiques d’analyse : un pipeline de projets toujours solid...

Nous avons sélectionné 10 graphiques afin d’identifier les principaux drivers du secteur. Les Capex sont attendus en repli de 1.5% en 2026 après un rebond de 70% depuis le point bas de 2020. Cette baisse proviendra essentiellement du marché US (plus forte discipline compte tenu de points morts plus élevés). Nous privilégions SBM Offshore (Surperformance, OC 45 €), Vallourec (Surperformance, OC 22 € vs 20.8 €) et Technip Energies (Surperformance, OC 49 €) et adoptons une opinion plus prudente sur...

Baptiste Lebacq ... (+2)
  • Baptiste Lebacq
  • Jean-François Granjon

ODDO : 10 analysis charts: a pipeline of projects that remains solid

For the start of 2026, we have selected ten charts to identify the sector's main drivers. Capex is expected to fall by 1.5% in 2026 after a 70% rebound from the low point of 2020. This reduction will mainly come from the US market (greater discipline due to higher breakeven points). At this point in the year, we prefer SBM Offshore (Outperform, target price € 45), Vallourec (Outperform, target price € 22 vs € 20.8) and Technip Energies (Outperform, target price € 49) and have adopted a more caut...

 PRESS RELEASE

Transgene Announces Financial Calendar for 2026

Transgene Announces Financial Calendar for 2026 Strasbourg, France, February 4, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG) a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its financial reporting and Annual shareholders’ meeting dates for 2026: March 24, 2026:               2025 Fiscal Year Results April 29, 2026:                 First Quarter 2026 Financial Results May 13, 2026:                   Annual Shareholders’ Meeting September 24, 2026:       First Half 2026 Financial Results  November 9, 2026:     ...

 PRESS RELEASE

Transgene présente son calendrier de communication financière pour 202...

Transgene présente son calendrier de communication financière pour 2026 Strasbourg (France), le 4 février 2026, 17 h 45 – Transgene (Euronext Paris : TNG), société de biotechnologie qui conçoit et développe des immunothérapies reposant sur des vecteurs viraux contre les cancers, annonce aujourd'hui son calendrier de communication financière pour 2026 et la date de son Assemblée générale annuelle : 24 mars 2026 :                   Résultats annuels de l’exercice 2025 29 avril 2026 :                    Résultats financiers du premier trimestre 2026 13 mai 2026 :                     Assembl...

Nicolas David ... (+2)
  • Nicolas David
  • Nicolas Thorez

ODDO : Shift to more favourable cycle to ease AI pressure on sector va...

While we do not deny the uncertainties and risks associated with artificial intelligence (pricing pressures, organisational change, etc.), we remain constructive on this issue, given the significant volume opportunities in prospect for the sector with the integration of agentic AI. Moreover, improving growth momentum in 2026 should reduce pressure on sector valuations (discount >30% vs Stoxx 600 vs a premium of 10% four years ago). On this basis, we have upgraded Bechtle (Outperform vs Neutral),...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch